Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2026-02-17 @ 6:49 PM
Study NCT ID:
NCT03676192
Status:
COMPLETED
Last Update Posted:
2025-03-17
First Post:
2018-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer
Sponsor:
Celltrion
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-19
Completion Date Type:
ACTUAL
First Submit Date:
2018-09-06
First Submit QC Date:
None
Study First Post Date:
2018-09-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-19
Results First Submit QC Date:
None
Results First Post Date:
2025-03-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-19
Last Update Post Date:
2025-03-17
Last Update Post Date Type:
ACTUAL